Chronic pain clinical trials in Newmarket, Ontario

Name: Chronic pain clinical trials in Newmarket
Creator: Chronic Pain Canada

Trials

Recruiting or not yet

Trial sites

Trials with a site in Newmarket

6 trials, recruiting first

		Phase
A Phase 3 Study of Tanezumab for Chronic Low Back Pain NCT02528253	Completed	Phase 3	Pfizer	2015-08-18
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina NCT01425359	Completed	Phase 4	Gilead Sciences	2011-09
A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis NCT01094262	Terminated	Phase 2	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2010-04-20
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain NCT00973141	Terminated	Phase 2	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2009-09-16
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain NCT00973024	Terminated	Phase 2	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2009-09
Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use" NCT00139776	Completed	Phase 4	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	2005-07

Facility names are as entered by study registrants. This is not a clinic directory.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.